Collaboration Agreements (675)
Collaboration agreements include contracts that define joint initiatives between a company and other parties.
Browse by Industry
- Auto Components (2)
- Biotechnology (520)
- Chemicals (4)
- Communications Equipment (2)
- Consumer Finance (4)
- Diversified Consumer Services (1)
- Electrical Equipment (2)
- Entertainment (1)
- Food Products (1)
- Health Care Equipment & Supplies (14)
- Health Care Providers & Services (1)
- Health Care Technology (3)
- Independent Power and Renewable Electricity Producers (1)
- Life Sciences Tools & Services (9)
- Metals & Mining (3)
- Oil, Gas & Consumable Fuels (1)
- Pharmaceuticals (68)
- Semiconductors & Semiconductor Equipment (2)
- Software (1)
- SPACs, Investment, and Acquisition Companies (1)
- Specialty Retail (1)
- Unassigned Industry (33)
- Collaboration and License Agreement, dated September 26, 2019, between Beam Therapeutics (Prime Medicine, Inc., Filed With SEC on September 23, 2022)
- Nuton Collaboration Agreement by and among McEwen Copper Inc., McEwen Mining Inc., Robert McEwen and Nuton LLC dated August 30, 2022 (McEwen Mining Inc., Filed With SEC on September 6, 2022)
- English Translation of Form Regional Service Provider Collaboration Agreement dated July 31, 2022 (Gushen, Inc, Filed With SEC on August 22, 2022)
- Clinical Trial Collaboration and Supply Agreement, dated August 1, 2022, by and between Context Therapeutics Inc. and Berlin-Chemie AG - Menarini Group (Context Therapeutics Inc., Filed With SEC on August 11, 2022)
- Amendment, dated August 4, 2022, to License, Collaboration and Supply Agreement by and between the Subsidiary and CMS Bridging DMCC (CAPSTAR SPECIAL PURPOSE ACQUISITION CORP., Filed With SEC on August 10, 2022)
- License and Collaboration Agreement between Felicitex Therapeutics Inc. and Diaxonhit, dated April 16, 2014 (Felicitex Therapeutics Inc., Filed With SEC on August 10, 2022)
- Amendment No. 1 to License and Collaboration Agreement between Felicitex Therapeutics Inc. and Diaxonhit, dated July 21, 2014 (Felicitex Therapeutics Inc., Filed With SEC on August 10, 2022)
- Amendment No. 2 to License and Collaboration Agreement between Felicitex Therapeutics Inc. and Eurobio Scientific SA (formerly Diaxonhit), dated February 14, 2022 (Felicitex Therapeutics Inc., Filed With SEC on August 10, 2022)
- Second Amendment to Collaboration and Commercialization Agreement, by and between the Subsidiary and Ascensia Diabetes Care Holdings AG, dated as of June 21, 2022 (Senseonics Holdings, Inc., Filed With SEC on August 9, 2022)
- Amendment No. 1 to the Definitive Collaboration Agreement between the Company and Glaxo Wellcome UK Limited dated May 27, 2022 (Vir Biotechnology, Inc., Filed With SEC on August 9, 2022)
